In 2013, over 1.6 million people were diagnosed with cancer and over 500,000 cancer-related deaths occurred in the U.S. alone. Cancer is one of the leading causes of death, worldwide, and new integrated treatments are being utilized to help combat its devastating effects.
Hyperbaric oxygen therapy (HBOT) is currently being utilized in conjunction with conventional treatments, including radiation and chemotherapy, to attain optimal dosages for patients, stimulate tumor regression and reduce the side effects of treatments. Cancer thrives in hypoxic or low-oxygen environments and HBOT has been shown to increase these oxygen levels to weaken tumors and reduce their aggressiveness.
Studies have demonstrated the benefits of HBOT for cancer with the following:
Scroll to the bottom of this page for supporting research.